ORGANOGENESIS HOLDINGS INC. Current Assets
ORGANOGENESIS HOLDINGS INC. (ORGO) had Current Assets of $200.30 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $200.30M.
- 2026-03-31: Assets, Current $268.50M.
- 2025-12-31: Assets, Current $362.19M.
- 2025-09-30: Assets, Current $299.75M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $200.30M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $268.50M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $362.19M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $299.75M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $260.22M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $268.16M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $285.94M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $238.51M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $234.19M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $227.17M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $225.04M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $225.57M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $216.44M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $216.82M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $222.61M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $230.53M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $231.54M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $217.85M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $226.98M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $211.84M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $201.76M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $185.24M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $174.34M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $129.01M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $117.71M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $111.40M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $125.60M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $80.84M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $76.15M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $85.06M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $71.13M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $25.01K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $160.47K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $269.30K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $49.74M 10-K · filed 2019-03-18 | $294.44K 10-K · filed 2018-03-14 |
| 2017-09-30 | $360.03K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $602.92K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $879.73K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $1.44M 10-K · filed 2018-03-14 | |
| 2015-12-31 | $126.06K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |